Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01246492

The Effect of Artificial Sweeteners on Blood Glucose Response

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether the presece of the artificial sweeteners aspartame, saccharin and asceulfame-k affect the blood glucose responses to an orally incested glucose solution.

Detailed description

Sweet taste receptors, similar to those located on the lingual taste buds have been located along in the lining of the gut. Recent studies have demonstrated that activation of these sweetness taste receptors, either by sugars such as glucose, fructose, lactose, or artificial sweeteners such as saccharin and aspartame can influence the way nutrients, including glucose are absorbed from the gut into the bloodstream. Studies in animal models have shown that activation of the sweet taste receptors can increase the expression of the sodium-dependant glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2) which transport glucose from the lumen into the bloodstream. Thus providing a potential mechanism by which glucose uptake can be regulated. Although artificial sweeteners stimulate the sweet taste receptors, they have little nutritive value, so that when they are consumed in the absence of any other nutrients there is little effect on blood glucose response. However, the effects of consuming artificial sweeteners in combination with sugars such as glucose is unclear. The purpose of this study is to investigate whether the addition of artificial sweeteners to an orally consumed glucose solution affects the rate at which the glucose appears in the blood.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTArtificial SweetenersA 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

Timeline

Start date
2010-11-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2010-11-23
Last updated
2012-05-18

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01246492. Inclusion in this directory is not an endorsement.